IKK alpha selective inhibitors (Cancer Research Technology)

N/A

Report date: 2025/01/26 18:48:12
NME

Base Information

Drug NameIKK alpha selective inhibitors (Cancer Research Technology)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInhibitor of nuclear factor kappa-B kinase subunit alpha inhibitors
TargetsInhibitor of nuclear factor kappa-B kinase subunit alpha
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCancer Research Technology
China Registration ClassN/A

Develop Information

Active CompaniesCancer Research Technology
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A